Inversion Therapeutics

Burlingame, CA · Founded 2025 · Privately Held (backing)

Developer of an oncology biotech platform designed to discover and progress therapies against previously untapped cancer mechanisms. Inversion Therapeutics is based in Burlingame, CA and was founded in 2025. It was valued at $17 million at its seed round in Aug 2025, the last priced event on record. It has raised $6.9 million across 1 recorded round; the latest was a $6.9 million early-stage round in Jun 2025.

PMV mark · valuation
$17.0M
Oct 2026
Priced at
its seed round
Aug 2025
Total raised
$6.9M
Last round
Early Stage VC
Jun 2025
What is Inversion Therapeutics worth?
$17.0MPrivateMarketView mark · Oct 2026

Valued at $17.0M at its seed round, Aug 2025. Nothing has traded since.

Free account
More of Inversion Therapeutics with a free account
  • ·Watch Inversion Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Inversion Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Jun 2025Early Stage VC$6.9M▮
Unlock post-money valuations

Membership and data by Private Market View

Inversion Therapeutics valuation

Inversion Therapeutics was valued at $17 million at its seed round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Inversion Therapeutics raised?

Inversion Therapeutics has raised $6.9 million across 1 recorded round since 2025. The largest was a $6.9 million early-stage round in Jun 2025.

Inversion Therapeutics has filed 1 Form D with the SEC, most recently in Aug 2025 ($6.9 million sold to 4 investors).

How Inversion Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Inversion Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Inversion Therapeutics

What is Inversion Therapeutics worth?
Inversion Therapeutics is valued at $17.0M as of Oct 2026. Valued at $17.0M at its seed round, Aug 2025. Nothing has traded since.
How much has Inversion Therapeutics raised?
Inversion Therapeutics has raised $6.9M in total funding across 1 recorded rounds.
When did Inversion Therapeutics last raise?
Inversion Therapeutics last raised in Jun 2025 (Early Stage VC), raising $6.9M.